IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharmaceuticals, Inc.

Q4 2024 Holdings

Filed 2025-02-07 | 6 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alnylam Pharmaceuticals, Inc.(ALNY)Common Stock02043Q107$1.0B4,444,44595.5%
Intellia Therapeutics, Inc.(NTLA)Common Stock45826J105$43.2M3,702,9953.9%
2seventy bio, Inc.(TSVT*)Common Stock901384107$3.7M1,254,8270.3%
Adicet Bio, Inc.(TORCEUR)Common Stock007002108$931.4K968,1830.1%
Adverum Biotechnologies, Inc.(AVU0)Common Stock00773U207$844.8K180,9090.1%
bluebird bio, Inc.(BLE0)Common Stock09609G209$175.1K21,0000.0%